DeutschNewstral
Article
Star Tribune on 2023-04-26 13:00
FDA lifts restrictions on Medtronic's diabetes business
Related news
- FDA issues warning to Medtronic's diabetes businessStar Tribune
- Another FDA recall for Medtronic's HeartWare deviceStar Tribune
- Despite FDA warning from past recalls, agency OKs Medtronic's new insulin pumpStar Tribune
How Does Medtronic's Diabetes Care Business Compare To Its Peers?Forbes
FDA Clears Medtronic's VenaSealwsj.com- FDA imposes "Class I" recall status on Medtronic's latest HeartWare defectStar Tribune
- FDA issues Class I recall for software glitch in Medtronic's surgery StealthStationStar Tribune
Medtronic's artery-clearing balloon wins FDA approvalbizjournals.com- FDA clears Medtronic's MRI-safe defibrillatorbizjournals.com
FDA lifts in-person restrictions on abortion pillAlaska Dispatch News- Medtronic's tiny leadless pacemaker gets FDA approvalbizjournals.com
- Medtronic's Drug Coated Balloon Enters U.S. With FDA ApprovalForbes
- EFDA lifts restrictions on Ohio-based Battelle's mask-sterilizing technology amid coronavirus shortageseu.usatoday.com
- Diabetes Will Lead Medtronic's Near Term Earnings GrowthForbes
- FDA: Medtronic slow to update, recall defective insulin pumps for diabetes patientsStar Tribune
- Another problem appears for Medtronic's HeartWare deviceStar Tribune
FDA approves 'artificial pancreas' to manage diabetesChicago Tribune
FDA Approves Lilly/Ingelheim Diabetes Treatmentinsideindianabusiness.com